智通港股股东权益披露|11月19日
Core Insights - The latest shareholder equity disclosure for Yuan Da Pharmaceutical (00512) was conducted on November 19, 2025 [1] Shareholding Changes - Tang Weikun increased his holdings in Yuan Da Pharmaceutical from 950,000 shares to 1,000,000 shares, representing a holding percentage of 0.03% [2]